Industry Research Reports

Home > Reports > Service & Software > Global Biolayer Interferometry (BLI) Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Biolayer Interferometry (BLI) Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-08-05

Pages: 143 Pages

Report ld: 4881278

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Biolayer Interferometry (BLI) Market Size(US$)

CAGR 2025-2031

9.4%

Market Size,2031

USD 668

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 391 million

Market Forecast in 2031(Value)

US$ 668 million

CAGR

9.4%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Biolayer Interferometry (BLI) market is projected to grow from US$ 370 million in 2024 to US$ 668 million by 2031, at a CAGR of 9.4% (2025-2031), driven by critical product segments and diverse end‑use applications.

Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.

The Biolayer Interferometry (BLI) market has been expanding rapidly due to its increasing use in a wide range of applications such as drug discovery, biotechnology, diagnostics, and life sciences research. BLI is a powerful, label-free, and real-time optical biosensing technique that is widely used for studying molecular interactions. Here are the most prominent market trends for BLI:

BLI is becoming an essential tool in drug discovery and biopharmaceutical development. The technique is crucial for assessing the interactions of small molecules, antibodies, peptides, and other therapeutics with biological targets. BLI is particularly useful in the screening of drug candidates, kinetic analysis, and the characterization of biologics like monoclonal antibodies and biosimilars.

With increased emphasis on biologics, biomolecular interactions, and antibody-drug conjugates (ADCs), the demand for BLI instruments is surging in pharmaceutical research labs, contract research organizations (CROs), and biotechnology companies.

One of the key advantages of BLI is its ability to monitor biomolecular interactions in real-time without the need for labels like fluorescence or radioactivity. This is especially important for applications in kinetic studies, where changes in molecular binding or dissociation are observed in real time. The technology’s label-free nature also makes it a more cost-effective and sustainable option compared to traditional assays.

Real-time monitoring allows for high-throughput analysis, which is essential for large-scale drug screening campaigns and biomarker discovery.

The BLI market is benefiting from its integration with high-throughput screening (HTS) platforms. The combination of label-free detection and the ability to screen large numbers of samples in a short time is making BLI a popular choice in drug development and compound screening. This integration is especially useful for accelerating the early stages of drug discovery.

Many manufacturers are developing BLI systems that can be easily integrated into existing HTS workflows, improving efficiency and throughput while providing high-quality interaction data.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biolayer Interferometry (BLI) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Ichor Life Sciences, Inc
Creative BioMart
GenScript
ROCKLAND IMMUNOCHEMICALS, INC
BPS Bioscience, Inc
Creative Proteomics
Creative Biostructure
Profacgen
Creative Biolabs
Biocult
KMD Bioscience Co., Ltd

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Affinity and Kinetic Analysis
Drug and Antibody Screening
Drug and Antibody Discovery
Protein Quantification
Others

Segment by Application

Pharmaceutical Industry
Diagnostics
Biotechnology
Scientific Research
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Biolayer Interferometry (BLI) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.

Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.

Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.

Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.

Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.

Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles

Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.

Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Biolayer Interferometry (BLI): Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Biolayer Interferometry (BLI) Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Affinity and Kinetic Analysis

1.2.3 Drug and Antibody Screening

1.2.4 Drug and Antibody Discovery

1.2.5 Protein Quantification

1.2.6 Others

1.3 Market Segmentation by Application

1.3.1 Global Biolayer Interferometry (BLI) Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Industry

1.3.3 Diagnostics

1.3.4 Biotechnology

1.3.5 Scientific Research

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Biolayer Interferometry (BLI) Revenue Estimates and Forecasts 2020-2031

2.2 Global Biolayer Interferometry (BLI) Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Biolayer Interferometry (BLI) Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Biolayer Interferometry (BLI) Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Affinity and Kinetic Analysis Market Size by Players

3.3.2 Drug and Antibody Screening Market Size by Players

3.3.3 Drug and Antibody Discovery Market Size by Players

3.3.4 Protein Quantification Market Size by Players

3.3.5 Others Market Size by Players

3.4 Global Biolayer Interferometry (BLI) Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Biolayer Interferometry (BLI) Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Biolayer Interferometry (BLI) Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Biolayer Interferometry (BLI) Market Size by Type (2020-2031)

6.4 North America Biolayer Interferometry (BLI) Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Biolayer Interferometry (BLI) Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Biolayer Interferometry (BLI) Market Size by Type (2020-2031)

7.4 Europe Biolayer Interferometry (BLI) Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Biolayer Interferometry (BLI) Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Type (2020-2031)

8.4 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Biolayer Interferometry (BLI) Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Biolayer Interferometry (BLI) Market Size by Type (2020-2031)

9.4 Central and South America Biolayer Interferometry (BLI) Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Biolayer Interferometry (BLI) Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Biolayer Interferometry (BLI) Market Size by Type (2020-2031)

10.4 Middle East and Africa Biolayer Interferometry (BLI) Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Biolayer Interferometry (BLI) Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Ichor Life Sciences, Inc

11.1.1 Ichor Life Sciences, Inc Corporation Information

11.1.2 Ichor Life Sciences, Inc Business Overview

11.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product Features and Attributes

11.1.4 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.1.5 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue by Product in 2024

11.1.6 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue by Application in 2024

11.1.7 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue by Geographic Area in 2024

11.1.8 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) SWOT Analysis

11.1.9 Ichor Life Sciences, Inc Recent Developments

11.2 Creative BioMart

11.2.1 Creative BioMart Corporation Information

11.2.2 Creative BioMart Business Overview

11.2.3 Creative BioMart Biolayer Interferometry (BLI) Product Features and Attributes

11.2.4 Creative BioMart Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.2.5 Creative BioMart Biolayer Interferometry (BLI) Revenue by Product in 2024

11.2.6 Creative BioMart Biolayer Interferometry (BLI) Revenue by Application in 2024

11.2.7 Creative BioMart Biolayer Interferometry (BLI) Revenue by Geographic Area in 2024

11.2.8 Creative BioMart Biolayer Interferometry (BLI) SWOT Analysis

11.2.9 Creative BioMart Recent Developments

11.3 GenScript

11.3.1 GenScript Corporation Information

11.3.2 GenScript Business Overview

11.3.3 GenScript Biolayer Interferometry (BLI) Product Features and Attributes

11.3.4 GenScript Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.3.5 GenScript Biolayer Interferometry (BLI) Revenue by Product in 2024

11.3.6 GenScript Biolayer Interferometry (BLI) Revenue by Application in 2024

11.3.7 GenScript Biolayer Interferometry (BLI) Revenue by Geographic Area in 2024

11.3.8 GenScript Biolayer Interferometry (BLI) SWOT Analysis

11.3.9 GenScript Recent Developments

11.4 ROCKLAND IMMUNOCHEMICALS, INC

11.4.1 ROCKLAND IMMUNOCHEMICALS, INC Corporation Information

11.4.2 ROCKLAND IMMUNOCHEMICALS, INC Business Overview

11.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product Features and Attributes

11.4.4 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.4.5 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue by Product in 2024

11.4.6 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue by Application in 2024

11.4.7 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue by Geographic Area in 2024

11.4.8 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) SWOT Analysis

11.4.9 ROCKLAND IMMUNOCHEMICALS, INC Recent Developments

11.5 BPS Bioscience, Inc

11.5.1 BPS Bioscience, Inc Corporation Information

11.5.2 BPS Bioscience, Inc Business Overview

11.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product Features and Attributes

11.5.4 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.5.5 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue by Product in 2024

11.5.6 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue by Application in 2024

11.5.7 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue by Geographic Area in 2024

11.5.8 BPS Bioscience, Inc Biolayer Interferometry (BLI) SWOT Analysis

11.5.9 BPS Bioscience, Inc Recent Developments

11.6 Creative Proteomics

11.6.1 Creative Proteomics Corporation Information

11.6.2 Creative Proteomics Business Overview

11.6.3 Creative Proteomics Biolayer Interferometry (BLI) Product Features and Attributes

11.6.4 Creative Proteomics Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.6.5 Creative Proteomics Recent Developments

11.7 Creative Biostructure

11.7.1 Creative Biostructure Corporation Information

11.7.2 Creative Biostructure Business Overview

11.7.3 Creative Biostructure Biolayer Interferometry (BLI) Product Features and Attributes

11.7.4 Creative Biostructure Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.7.5 Creative Biostructure Recent Developments

11.8 Profacgen

11.8.1 Profacgen Corporation Information

11.8.2 Profacgen Business Overview

11.8.3 Profacgen Biolayer Interferometry (BLI) Product Features and Attributes

11.8.4 Profacgen Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.8.5 Profacgen Recent Developments

11.9 Creative Biolabs

11.9.1 Creative Biolabs Corporation Information

11.9.2 Creative Biolabs Business Overview

11.9.3 Creative Biolabs Biolayer Interferometry (BLI) Product Features and Attributes

11.9.4 Creative Biolabs Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.9.5 Creative Biolabs Recent Developments

11.10 Biocult

11.10.1 Biocult Corporation Information

11.10.2 Biocult Business Overview

11.10.3 Biocult Biolayer Interferometry (BLI) Product Features and Attributes

11.10.4 Biocult Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 KMD Bioscience Co., Ltd

11.11.1 KMD Bioscience Co., Ltd Corporation Information

11.11.2 KMD Bioscience Co., Ltd Business Overview

11.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product Features and Attributes

11.11.4 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue and Gross Margin (2020-2025)

11.11.5 KMD Bioscience Co., Ltd Recent Developments

12 Biolayer Interferometry (BLI)Industry Chain Analysis

12.1 Biolayer Interferometry (BLI) Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Biolayer Interferometry (BLI) Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Biolayer Interferometry (BLI) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Biolayer Interferometry (BLI) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Biolayer Interferometry (BLI) Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Biolayer Interferometry (BLI) Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Biolayer Interferometry (BLI) Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Biolayer Interferometry (BLI) Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Biolayer Interferometry (BLI) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biolayer Interferometry (BLI) as of 2024)

Table 11. Global Biolayer Interferometry (BLI) Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Biolayer Interferometry (BLI) Companies Headquarters

Table 13. Global Biolayer Interferometry (BLI) Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Biolayer Interferometry (BLI) Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Biolayer Interferometry (BLI) Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Biolayer Interferometry (BLI) Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Biolayer Interferometry (BLI) Revenue by Application (2026-2031) & (US$ Million)

Table 21. Biolayer Interferometry (BLI) High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Biolayer Interferometry (BLI) Growth Accelerators and Market Barriers

Table 25. North America Biolayer Interferometry (BLI) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Biolayer Interferometry (BLI) Growth Accelerators and Market Barriers

Table 27. Europe Biolayer Interferometry (BLI) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Biolayer Interferometry (BLI) Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Biolayer Interferometry (BLI) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Biolayer Interferometry (BLI) Investment Opportunities and Key Challenges

Table 31. Central and South America Biolayer Interferometry (BLI) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Biolayer Interferometry (BLI) Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Biolayer Interferometry (BLI) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Ichor Life Sciences, Inc Corporation Information

Table 35. Ichor Life Sciences, Inc Description and Major Businesses

Table 36. Ichor Life Sciences, Inc Product Features and Attributes

Table 37. Ichor Life Sciences, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Ichor Life Sciences, Inc Revenue Proportion by Product in 2024

Table 39. Ichor Life Sciences, Inc Revenue Proportion by Application in 2024

Table 40. Ichor Life Sciences, Inc Revenue Proportion by Geographic Area in 2024

Table 41. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) SWOT Analysis

Table 42. Ichor Life Sciences, Inc Recent Developments

Table 43. Creative BioMart Corporation Information

Table 44. Creative BioMart Description and Major Businesses

Table 45. Creative BioMart Product Features and Attributes

Table 46. Creative BioMart Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Creative BioMart Revenue Proportion by Product in 2024

Table 48. Creative BioMart Revenue Proportion by Application in 2024

Table 49. Creative BioMart Revenue Proportion by Geographic Area in 2024

Table 50. Creative BioMart Biolayer Interferometry (BLI) SWOT Analysis

Table 51. Creative BioMart Recent Developments

Table 52. GenScript Corporation Information

Table 53. GenScript Description and Major Businesses

Table 54. GenScript Product Features and Attributes

Table 55. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. GenScript Revenue Proportion by Product in 2024

Table 57. GenScript Revenue Proportion by Application in 2024

Table 58. GenScript Revenue Proportion by Geographic Area in 2024

Table 59. GenScript Biolayer Interferometry (BLI) SWOT Analysis

Table 60. GenScript Recent Developments

Table 61. ROCKLAND IMMUNOCHEMICALS, INC Corporation Information

Table 62. ROCKLAND IMMUNOCHEMICALS, INC Description and Major Businesses

Table 63. ROCKLAND IMMUNOCHEMICALS, INC Product Features and Attributes

Table 64. ROCKLAND IMMUNOCHEMICALS, INC Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. ROCKLAND IMMUNOCHEMICALS, INC Revenue Proportion by Product in 2024

Table 66. ROCKLAND IMMUNOCHEMICALS, INC Revenue Proportion by Application in 2024

Table 67. ROCKLAND IMMUNOCHEMICALS, INC Revenue Proportion by Geographic Area in 2024

Table 68. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) SWOT Analysis

Table 69. ROCKLAND IMMUNOCHEMICALS, INC Recent Developments

Table 70. BPS Bioscience, Inc Corporation Information

Table 71. BPS Bioscience, Inc Description and Major Businesses

Table 72. BPS Bioscience, Inc Product Features and Attributes

Table 73. BPS Bioscience, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. BPS Bioscience, Inc Revenue Proportion by Product in 2024

Table 75. BPS Bioscience, Inc Revenue Proportion by Application in 2024

Table 76. BPS Bioscience, Inc Revenue Proportion by Geographic Area in 2024

Table 77. BPS Bioscience, Inc Biolayer Interferometry (BLI) SWOT Analysis

Table 78. BPS Bioscience, Inc Recent Developments

Table 79. Creative Proteomics Corporation Information

Table 80. Creative Proteomics Description and Major Businesses

Table 81. Creative Proteomics Product Features and Attributes

Table 82. Creative Proteomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Creative Proteomics Recent Developments

Table 84. Creative Biostructure Corporation Information

Table 85. Creative Biostructure Description and Major Businesses

Table 86. Creative Biostructure Product Features and Attributes

Table 87. Creative Biostructure Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Creative Biostructure Recent Developments

Table 89. Profacgen Corporation Information

Table 90. Profacgen Description and Major Businesses

Table 91. Profacgen Product Features and Attributes

Table 92. Profacgen Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Profacgen Recent Developments

Table 94. Creative Biolabs Corporation Information

Table 95. Creative Biolabs Description and Major Businesses

Table 96. Creative Biolabs Product Features and Attributes

Table 97. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Creative Biolabs Recent Developments

Table 99. Biocult Corporation Information

Table 100. Biocult Description and Major Businesses

Table 101. Biocult Product Features and Attributes

Table 102. Biocult Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Biocult Recent Developments

Table 104. KMD Bioscience Co., Ltd Corporation Information

Table 105. KMD Bioscience Co., Ltd Description and Major Businesses

Table 106. KMD Bioscience Co., Ltd Product Features and Attributes

Table 107. KMD Bioscience Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. KMD Bioscience Co., Ltd Recent Developments

Table 109. Raw Materials Key Suppliers

Table 110. Distributors List

Table 111. Market Trends and Market Evolution

Table 112. Market Drivers and Opportunities

Table 113. Market Challenges, Risks, and Restraints

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Biolayer Interferometry (BLI) Product Picture

Figure 2. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Affinity and Kinetic Analysis Product Picture

Figure 4. Drug and Antibody Screening Product Picture

Figure 5. Drug and Antibody Discovery Product Picture

Figure 6. Protein Quantification Product Picture

Figure 7. Others Product Picture

Figure 8. Global Biolayer Interferometry (BLI) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Pharmaceutical Industry

Figure 10. Diagnostics

Figure 11. Biotechnology

Figure 12. Scientific Research

Figure 13. Others

Figure 14. Biolayer Interferometry (BLI) Report Years Considered

Figure 15. Global Biolayer Interferometry (BLI) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 17. Global Biolayer Interferometry (BLI) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 18. Global Biolayer Interferometry (BLI) Revenue Market Share by Region (2020-2031)

Figure 19. Global Biolayer Interferometry (BLI) Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. Affinity and Kinetic Analysis Revenue Market Share by Player in 2024

Figure 22. Drug and Antibody Screening Revenue Market Share by Player in 2024

Figure 23. Drug and Antibody Discovery Revenue Market Share by Player in 2024

Figure 24. Protein Quantification Revenue Market Share by Player in 2024

Figure 25. Others Revenue Market Share by Player in 2024

Figure 26. Global Biolayer Interferometry (BLI) Revenue Market Share by Type (2020-2031)

Figure 27. Global Biolayer Interferometry (BLI) Revenue Market Share by Application (2020-2031)

Figure 28. North America Biolayer Interferometry (BLI) Revenue YoY (2020-2031) & (US$ Million)

Figure 29. North America Top 5 Players Biolayer Interferometry (BLI) Revenue (US$ Million) in 2024

Figure 30. North America Biolayer Interferometry (BLI) Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Biolayer Interferometry (BLI) Revenue (US$ Million) by Application (2020-2031)

Figure 32. US Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 33. Canada Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 34. Mexico Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 35. Europe Biolayer Interferometry (BLI) Revenue YoY (2020-2031) & (US$ Million)

Figure 36. Europe Top 5 Players Biolayer Interferometry (BLI) Revenue (US$ Million) in 2024

Figure 37. Europe Biolayer Interferometry (BLI) Revenue (US$ Million) by Type (2020-2031)

Figure 38. Europe Biolayer Interferometry (BLI) Revenue (US$ Million) by Application (2020-2031)

Figure 39. Germany Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 40. France Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 41. U.K. Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 42. Italy Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 43. Russia Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 44. Asia-Pacific Biolayer Interferometry (BLI) Revenue YoY (2020-2031) & (US$ Million)

Figure 45. Asia-Pacific Top 8 Players Biolayer Interferometry (BLI) Revenue (US$ Million) in 2024

Figure 46. Asia-Pacific Biolayer Interferometry (BLI) Revenue (US$ Million) by Type (2020-2031)

Figure 47. Asia-Pacific Biolayer Interferometry (BLI) Revenue (US$ Million) by Application (2020-2031)

Figure 48. Indonesia Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 49. Japan Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 50. South Korea Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 51. Australia Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 52. India Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 53. Indonesia Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 54. Vietnam Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 55. Malaysia Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 56. Philippines Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 57. Singapore Biolayer Interferometry (BLI) Revenue (2020-2031) & (US$ Million)

Figure 58. Central and South America Biolayer Interferometry (BLI) Revenue YoY (2020-2031) & (US$ Million)

Figure 59. Central and South America Top 5 Players Biolayer Interferometry (BLI) Revenue (US$ Million) in 2024

Figure 60. Central and South America Biolayer Interferometry (BLI) Revenue (US$ Million) by Type (2020-2031)

Figure 61. Central and South America Biolayer Interferometry (BLI) Revenue (US$ Million) by Application (2020-2031)

Figure 62. Brazil Biolayer Interferometry (BLI) Revenue (2020-2025) & (US$ Million)

Figure 63. Argentina Biolayer Interferometry (BLI) Revenue (2020-2025) & (US$ Million)

Figure 64. Middle East and Africa Biolayer Interferometry (BLI) Revenue YoY (2020-2031) & (US$ Million)

Figure 65. Middle East and Africa Top 5 Players Biolayer Interferometry (BLI) Revenue (US$ Million) in 2024

Figure 66. South America Biolayer Interferometry (BLI) Revenue (US$ Million) by Type (2020-2031)

Figure 67. Middle East and Africa Biolayer Interferometry (BLI) Revenue (US$ Million) by Application (2020-2031)

Figure 68. GCC Countries Biolayer Interferometry (BLI) Revenue (2020-2025) & (US$ Million)

Figure 69. Israel Biolayer Interferometry (BLI) Revenue (2020-2025) & (US$ Million)

Figure 70. Egypt Biolayer Interferometry (BLI) Revenue (2020-2025) & (US$ Million)

Figure 71. South Africa Biolayer Interferometry (BLI) Revenue (2020-2025) & (US$ Million)

Figure 72. Biolayer Interferometry (BLI) Industry Chain Mapping

Figure 73. Channels of Distribution (Direct Vs Distribution)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Biolayer Interferometry (BLI) market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Biolayer Interferometry (BLI) market is 9.4% 2025 to 2031.

What was the global market size of Biolayer Interferometry (BLI) in 2031? shouQi

Which companies rank high in the global Biolayer Interferometry (BLI) market? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Biolayer Interferometry (BLI) in 2025? shouQi

Related Reports

Global Biolayer Interferometry (BLI) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Biolayer Interferometry (BLI) market is projected to grow from US$ 391 million in 2025 to US$ 724 million by 2032, at a CAGR of 9.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 139
USD 4900.00
(Single User License)
Global Biolayer Interferometry (BLI) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Biolayer Interferometry (BLI) market size was US$ 391 million in 2025 and is forecast to reach a readjusted size of US$ 724 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
Biolayer Interferometry (BLI) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biolayer Interferometry (BLI) was estimated to be worth US$ 391 million in 2025 and is projected to reach US$ 724 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 112
USD 3950.00
(Single User License)
Global Biolayer Interferometry (BLI) Market Research Report 2026
The global Biolayer Interferometry (BLI) market was valued at US$ 391 million in 2025 and is anticipated to reach US$ 724 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-01-14
Pages: 119
USD 2900.00
(Single User License)
Global Biolayer Interferometry (BLI) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biolayer Interferometry (BLI) market size was US$ 370 million in 2024 and is forecast to a readjusted size of US$ 668 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 94
USD 4250.00
(Single User License)
Biolayer Interferometry (BLI) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biolayer Interferometry (BLI) was estimated to be worth US$ 370 million in 2024 and is forecast to a readjusted size of US$ 668 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 109
USD 3950.00
(Single User License)
Global Biolayer Interferometry (BLI) Market Research Report 2025
The global market for Biolayer Interferometry (BLI) was valued at US$ 370 million in the year 2024 and is projected to reach a revised size of US$ 668 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Published Date: 2025-03-11
Pages: 87
USD 2900.00
(Single User License)
Global Biolayer Interferometry (BLI) Market Insights, Forecast to 2031
Valued at US$ 391 million in 2024, the global Biolayer Interferometry (BLI) market is forecast to reach US$ 668 million by 2030, at a CAGR of 9.4% during the forecast period.
Published Date: 2025-03-03
Pages: 135
USD 4900.00
(Single User License)
Global Biolayer Interferometry (BLI) Market Research Report 2024
Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
Published Date: 2024-06-11
Pages: 84
USD 2900.00
(Single User License)
Global and United States Biolayer Interferometry (BLI) Market Report & Forecast 2024-2030
Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
Published Date: 2024-06-11
Pages: 108
USD 4350.00
(Single User License)

Global Biolayer Interferometry (BLI) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Biolayer Interferometry (BLI) market is projected to grow from US$ 391 million in 2025 to US$ 724 million by 2032, at a CAGR of 9.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 139
USD 4900.00 (Single User License)
Global Biolayer Interferometry (BLI) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Biolayer Interferometry (BLI) market size was US$ 391 million in 2025 and is forecast to reach a readjusted size of US$ 724 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
USD 4250.00 (Single User License)
Biolayer Interferometry (BLI) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biolayer Interferometry (BLI) was estimated to be worth US$ 391 million in 2025 and is projected to reach US$ 724 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-01-19
Pages: 112
USD 3950.00 (Single User License)
Global Biolayer Interferometry (BLI) Market Research Report 2026
The global Biolayer Interferometry (BLI) market was valued at US$ 391 million in 2025 and is anticipated to reach US$ 724 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-01-14
Pages: 119
USD 2900.00 (Single User License)
Global Biolayer Interferometry (BLI) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biolayer Interferometry (BLI) market size was US$ 370 million in 2024 and is forecast to a readjusted size of US$ 668 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 94
USD 4250.00 (Single User License)
Biolayer Interferometry (BLI) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biolayer Interferometry (BLI) was estimated to be worth US$ 370 million in 2024 and is forecast to a readjusted size of US$ 668 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 109
USD 3950.00 (Single User License)
Global Biolayer Interferometry (BLI) Market Research Report 2025
The global market for Biolayer Interferometry (BLI) was valued at US$ 370 million in the year 2024 and is projected to reach a revised size of US$ 668 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Published: 2025-03-11
Pages: 87
USD 2900.00 (Single User License)
Global Biolayer Interferometry (BLI) Market Insights, Forecast to 2031
Valued at US$ 391 million in 2024, the global Biolayer Interferometry (BLI) market is forecast to reach US$ 668 million by 2030, at a CAGR of 9.4% during the forecast period.
Published: 2025-03-03
Pages: 135
USD 4900.00 (Single User License)
Global Biolayer Interferometry (BLI) Market Research Report 2024
Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
Published: 2024-06-11
Pages: 84
USD 2900.00 (Single User License)
Global and United States Biolayer Interferometry (BLI) Market Report & Forecast 2024-2030
Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.
Published: 2024-06-11
Pages: 108
USD 4350.00 (Single User License)